Pharmacy Benefit Management Global Strategic Business Report 2024: Increasing Prescription Drug Costs Propel Demand - Forecasts to 2030
July 08, 2024 10:09 ET
|
Research and Markets
Dublin, July 08, 2024 (GLOBE NEWSWIRE) -- The "Pharmacy Benefit Management - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
NASP Petitions SCOTUS to Reverse Lower Court Decision on Oklahoma Law and to Protect Specialty Pharmacies
June 15, 2024 09:21 ET
|
National Association of Specialty Pharmacy (NASP)
Washington, DC, June 15, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) has filed a petition before the U.S. Supreme Court, asking that the Court agree to support the...
NASP Releases Agenda for its 2024 Annual Meeting & Expo
June 04, 2024 09:26 ET
|
National Association of Specialty Pharmacy (NASP)
Washington, DC, June 04, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is...
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
June 03, 2024 08:00 ET
|
Avricore Health Inc.
Q1 2024 Results
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
May 21, 2024 08:45 ET
|
Dalrada Financial Corp.
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 20, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 20, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Colorectal Cancer Market Size, Trends and Insights By Type of Treatment (Surgery,...
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
May 16, 2024 08:45 ET
|
Dalrada Financial Corp.
Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue
MRSA Drugs Global Strategic Research Report 2024: Market to Reach $1.6 Billion by 2030 - Glycopeptides & Lipoglycopeptides to Account for $660 Million
May 13, 2024 09:55 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "MRSA Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global MRSA Drugs Market to Reach $1.6...
Compounding Pharmacy Global Strategic Business Report 2024: Market to Reach $17.7 Billion by 2030 from $13 Billion in 2023
May 13, 2024 09:49 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Compounding Pharmacy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Compounding Pharmacy Market...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
May 12, 2024 14:02 ET
|
The Rosen Law Firm PA
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September...